NCT06135233View on ClinicalTrials.gov

Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:

CompletedOBSERVATIONAL
Enrollment

1,336

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

January 1, 2022

Conditions
Pancreas Disease
Interventions
OTHER

No intervention

all patients undergoing minimally invasive pancreatic surgery, no intervention, no randomization

Trial Locations (1)

1105 AZ

Amsterdam UMC, locatie AMC, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT06135233 - Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe: | Biotech Hunter | Biotech Hunter